Alfresa Pharma Corporation

2010/08/04
Consolidated Financial Statements for the First Quarter of the Fiscal Year Ending March 31, 2011 New
2010/08/04
Announcement of Conclusion of Stock Exchange Agreement between Alfresa Holdings and TAMPEI NAKATA New
2010/07/01
Notice Concerning Transfer of Manufacturing and Marketing of Tofranil Tablets Used for the Treatment of Depression and Depressive Disorders As Well As Enuresis
2010/05/11
Consolidated Financial Statements for the Fiscal Year Ended March 31, 2010
2010/05/11
Announcement of Basic Agreement on Management Integration between Alfresa Holdings and TAMPEI NAKATA